Heartland Advisors Inc. Has $12.68 Million Stock Position in Teleflex Incorporated $TFX

Heartland Advisors Inc. decreased its stake in shares of Teleflex Incorporated (NYSE:TFXFree Report) by 30.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 103,927 shares of the medical technology company’s stock after selling 46,073 shares during the period. Heartland Advisors Inc. owned 0.24% of Teleflex worth $12,683,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Banque Cantonale Vaudoise lifted its position in Teleflex by 82.5% during the 4th quarter. Banque Cantonale Vaudoise now owns 250 shares of the medical technology company’s stock worth $31,000 after buying an additional 113 shares in the last quarter. Hantz Financial Services Inc. lifted its position in Teleflex by 248.8% during the 3rd quarter. Hantz Financial Services Inc. now owns 279 shares of the medical technology company’s stock worth $34,000 after buying an additional 199 shares in the last quarter. V Square Quantitative Management LLC acquired a new position in Teleflex during the 4th quarter worth about $37,000. Sound Income Strategies LLC acquired a new position in Teleflex during the 4th quarter worth about $45,000. Finally, Danske Bank A S acquired a new position in Teleflex during the 3rd quarter worth about $54,000. Institutional investors and hedge funds own 95.62% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on TFX. Bank of America upgraded shares of Teleflex from an “underperform” rating to a “neutral” rating and set a $135.00 price target on the stock in a research report on Monday, April 13th. Wells Fargo & Company upped their target price on shares of Teleflex from $130.00 to $138.00 and gave the company an “equal weight” rating in a research report on Friday, May 8th. Raymond James Financial restated an “outperform” rating and set a $150.00 target price on shares of Teleflex in a research report on Friday, May 8th. Needham & Company LLC upped their target price on shares of Teleflex from $138.00 to $147.00 and gave the company a “buy” rating in a research report on Thursday, February 26th. Finally, Piper Sandler upgraded shares of Teleflex from a “neutral” rating to an “overweight” rating and upped their target price for the company from $140.00 to $160.00 in a research report on Monday. Four research analysts have rated the stock with a Buy rating, five have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $146.00.

Get Our Latest Analysis on Teleflex

Teleflex Stock Performance

Teleflex stock opened at $132.27 on Thursday. The company has a current ratio of 2.55, a quick ratio of 2.03 and a debt-to-equity ratio of 0.82. Teleflex Incorporated has a 1 year low of $100.18 and a 1 year high of $139.67. The company has a market cap of $5.86 billion, a PE ratio of -5.80, a PEG ratio of 1.01 and a beta of 0.82. The company’s 50-day moving average is $128.24 and its two-hundred day moving average is $118.71.

Teleflex (NYSE:TFXGet Free Report) last released its earnings results on Thursday, May 7th. The medical technology company reported $1.39 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.21 by $0.18. The company had revenue of $548.30 million for the quarter, compared to the consensus estimate of $536.91 million. Teleflex had a negative net margin of 35.88% and a positive return on equity of 13.29%. The company’s revenue was up 32.3% compared to the same quarter last year. During the same period in the prior year, the company posted $1.44 EPS. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. Equities analysts anticipate that Teleflex Incorporated will post 6.7 earnings per share for the current year.

Teleflex Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Investors of record on Monday, May 25th will be given a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.0%. The ex-dividend date is Friday, May 22nd. Teleflex’s dividend payout ratio (DPR) is currently -5.96%.

Teleflex Company Profile

(Free Report)

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.

Read More

Institutional Ownership by Quarter for Teleflex (NYSE:TFX)

Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.